Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1991-9-12
|
pubmed:abstractText |
Immune deficiency generally leads to infections. Cancer chemotherapy, medical interventions and various investigational procedures are important factors in the development of infection. In recent decades, there has been a major change in most cancer centers in the etiology of bacterial infections occurring in the immunocompromised host, most infections now being caused by gram-positive organisms. This might be partly due to prophylactic use of agents effective against gram-negative bacteria. The quinolones are now widely used in the treatment of serious infections of the immunocompromised patient. Prophylaxis with quinolones is also practised in cancer centers.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0934-9723
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
10
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
361-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1864298-4-Quinolones,
pubmed-meshheading:1864298-Anti-Bacterial Agents,
pubmed-meshheading:1864298-Bacterial Infections,
pubmed-meshheading:1864298-Drug Administration Schedule,
pubmed-meshheading:1864298-Drug Therapy, Combination,
pubmed-meshheading:1864298-Humans,
pubmed-meshheading:1864298-Immune Tolerance,
pubmed-meshheading:1864298-Immunologic Deficiency Syndromes,
pubmed-meshheading:1864298-Leukopenia,
pubmed-meshheading:1864298-Neoplasms
|
pubmed:year |
1991
|
pubmed:articleTitle |
Use of quinolones in the immunocompromised host.
|
pubmed:affiliation |
Department of Radiotherapy and Oncology, Helsinki University Central Hospital, Finland.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Review
|